178 related articles for article (PubMed ID: 19931889)
1. The influence of citrate concentrations on PFA-100 closure times, platelet hyper-reactivity and aspirin monitoring.
Harrison P
Thromb Res; 2010 Aug; 126(2):e137-8. PubMed ID: 19931889
[No Abstract] [Full Text] [Related]
2. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
3. Influence of systemic inflammation on the interpretation of response to antiplatelet therapy, monitored by PFA-100.
Ziegler S; Alt E; Brunner M; Speiser W; Minar E
Semin Thromb Hemost; 2005; 31(4):416-9. PubMed ID: 16149019
[TBL] [Abstract][Full Text] [Related]
4. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
[TBL] [Abstract][Full Text] [Related]
5. Aspirin response variability assessed with the PFA-100 device.
Reny JL; Quéré I; de Moerloose P; Fontana P
Thromb Haemost; 2008 May; 99(5):968-9; author reply 969. PubMed ID: 18449432
[No Abstract] [Full Text] [Related]
6. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
[TBL] [Abstract][Full Text] [Related]
7. Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100.
Feuring M; Schultz A; Losel R; Wehling M
Semin Thromb Hemost; 2005; 31(4):411-5. PubMed ID: 16149018
[TBL] [Abstract][Full Text] [Related]
8. Using the Platelet Function Analyzer-100 for monitoring aspirin therapy.
Poulsen TS; Mickley H; Korsholm L; Licht PB; Haghfelt T; Jørgensen B
Thromb Res; 2007; 120(2):161-72. PubMed ID: 17052745
[TBL] [Abstract][Full Text] [Related]
9. Use of the platelet reactivity index by Grotemeyer, platelet function analyzer, and retention test Homburg to monitor therapy with antiplatelet drugs.
Koscielny J; Aslan T; Meyer O; Kiesewetter H; Jung F; Mrowietz C; Latza R
Semin Thromb Hemost; 2005; 31(4):464-9. PubMed ID: 16149025
[TBL] [Abstract][Full Text] [Related]
10. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment.
Paniccia R; Antonucci E; Gori AM; Marcucci R; Poli S; Romano E; Valente S; Giglioli C; Fedi S; Gensini GF; Abbate R; Prisco D
Am J Clin Pathol; 2007 Jul; 128(1):143-9. PubMed ID: 17580282
[TBL] [Abstract][Full Text] [Related]
12. Use of the platelet function analyser (PFA-100) to quantify the effect of low dose aspirin in patients with ischaemic heart disease.
Coakley M; Self R; Marchant W; Mackie I; Mallett SV; Mythen M
Anaesthesia; 2005 Dec; 60(12):1173-8. PubMed ID: 16288614
[TBL] [Abstract][Full Text] [Related]
13. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
[TBL] [Abstract][Full Text] [Related]
14. Comment on "hyperresponsiveness of platelets in ischemic stroke" by Fateh-Moghadam et al.
Smout J; Cleanthis M; Stansby G
Thromb Haemost; 2008 Jan; 99(1):239. PubMed ID: 18217162
[No Abstract] [Full Text] [Related]
15. Platelet function tests: a comparative review.
Paniccia R; Priora R; Liotta AA; Abbate R
Vasc Health Risk Manag; 2015; 11():133-48. PubMed ID: 25733843
[TBL] [Abstract][Full Text] [Related]
16. Monitoring platelet function by PFA-100 closure time measurements during thrombolytic therapy of patients with myocardial infarction.
Kerényi A; Soltész P; Veres K; Szegedi G; Muszbek L
Thromb Res; 2005; 116(2):139-44. PubMed ID: 15907529
[No Abstract] [Full Text] [Related]
17. The influence of clinical characteristics, laboratory and inflammatory markers on 'high on-treatment platelet reactivity' as measured with different platelet function tests.
Elsenberg EH; van Werkum JW; van de Wal RM; Zomer AC; Bouman HJ; Verheugt FW; Berg JM; Hackeng CM
Thromb Haemost; 2009 Oct; 102(4):719-27. PubMed ID: 19806258
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949
[TBL] [Abstract][Full Text] [Related]
19. Platelets and lipoprotein(a) in retinal vein occlusion: mutual targets for aspirin therapy.
Lippi G; Franchini M; Targher G
Thromb Haemost; 2007 Jun; 97(6):1059-60. PubMed ID: 17549315
[No Abstract] [Full Text] [Related]
20. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
